tiprankstipranks
THC Therapeutics Inc (THCT)
OTHER OTC:THCT
US Market
THCT
THC Therapeutics
RESEARCH TOOLSreports

THC Therapeutics (THCT) Ratios

33 Followers

THC Therapeutics Ratios

THCT's free cash flow for Q3 2024 was $0.00. For the 2024 fiscal year, THCT's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jul 23Jul 22Jul 21Jul 20
Liquidity Ratios
Current Ratio
 <0.01 <0.01 0.01 0.11 0.02
Quick Ratio
 <0.01 <0.01 0.01 0.11 0.02
Cash Ratio
 <0.01 <0.01 <0.01 0.10 0.02
Solvency Ratio
 -0.12 -0.12 -0.45 -0.63 -1.02
Operating Cash Flow Ratio
 -0.03 -0.03 -0.13 -0.14 -0.32
Short-Term Operating Cash Flow Coverage
 -0.11 -0.11 -0.52 -0.45 -1.37
Net Current Asset Value
$ -3.32M$ -3.32M$ -3.28M$ -2.66M$ -1.82M
Leverage Ratios
Debt-to-Assets Ratio
 60.93 60.93 3.87 1.59 5.04
Debt-to-Equity Ratio
 -0.24 -0.24 -0.26 -0.31 -0.24
Debt-to-Capital Ratio
 -0.31 -0.31 -0.35 -0.44 -0.32
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 >-0.01 >-0.01 -0.07 -0.19 -0.05
Debt Service Coverage Ratio
 -0.57 -0.57 -1.92 -0.66 -2.02
Interest Coverage Ratio
 -6.21 -6.21 -17.39 -1.70 -2.70
Debt to Market Cap
 40.73 1.13K 78.27 47.43 51.96
Interest Debt Per Share
 0.03 0.03 0.03 0.06 0.06
Net Debt to EBITDA
 -1.61 -1.61 -0.46 -0.50 -0.28
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
78.36%78.36%86.99%200.58%146.02%
Return on Assets (ROA)
-2979.49%-2979.49%-734.13%-392.75%-2255.73%
Return on Equity (ROE)
12.06%11.69%48.84%76.11%108.24%
Return on Capital Employed (ROCE)
15.39%15.39%58.01%39.54%74.12%
Return on Invested Capital (ROIC)
20.42%20.42%79.04%61.85%97.76%
Return on Tangible Assets
-39493.47%-39493.47%-784.98%-406.51%-2976.24%
Earnings Yield
-2359.54%-55056.01%-14841.25%-10426.83%-23263.13%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 <0.01 <0.01 0.02 0.04
Inventory Turnover
 0.00 0.00 493.36 19.72 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -507.45K -507.45K -46.78K -21.62K -10.37K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.74 18.51 0.00
Days of Payables Outstanding
 507.45K 507.45K 46.78K 21.64K 10.37K
Operating Cycle
 0.00 0.00 0.74 18.51 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -0.01 -0.02 -0.04
Free Cash Flow Per Share
 >-0.01 >-0.01 -0.01 -0.02 -0.04
CapEx Per Share
 0.00 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -139.64K -129.49K 0.00
Capital Expenditure Coverage Ratio
 0.00 0.00 -139.64K -129.49K 0.00
Operating Cash Flow Coverage Ratio
 -0.11 -0.11 -0.52 -0.51 -1.37
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-439.61%-12152.45%-4093.18%-2148.34%-7104.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.04 >-0.01 >-0.01 >-0.01 >-0.01
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.23 >-0.01 -0.02 -0.05 -0.01
Price-to-Operating Cash Flow Ratio
 -0.19 >-0.01 -0.02 -0.05 -0.01
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Price-to-Fair Value
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Enterprise Value Multiple
 -1.65 -1.61 -0.47 -0.52 -0.29
Enterprise Value
 810.86K 792.13K 811.23K 483.30K 395.08K
EV to EBITDA
 -1.65 -1.61 -0.47 -0.52 -0.29
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -9.49 -9.27 -1.94 -1.24 -0.67
EV to Operating Cash Flow
 -9.49 -9.27 -1.94 -1.24 -0.67
Tangible Book Value Per Share
 -0.10 -0.10 -0.09 -0.11 -0.11
Shareholders’ Equity Per Share
 -0.10 -0.10 -0.09 -0.10 -0.11
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.25
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -0.01 -0.01 -0.05 -0.08 -0.12
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.78 0.78 0.87 2.01 1.38
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.22 0.22 0.28 0.21 0.31
Currency in USD